Mirroring the shift in T-cell subsets that had been observed in tumor tissue, virotherapy and particularly MATE-virotherapy increased the amount of CD8+ T cells resulting in a more favorable ratio of CD8+ to CD4+ T cells. This evidence concerns the gene CD8A and neoplasm.